Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anionic biomolecules and surfaces represent a broad class of negatively charged biological structures that serve as essential components of cells and the extracellular environment. This category includes glycosaminoglycans like heparin, the phosphate backbone of nucleic acids, acidic phospholipids in cell membranes, and various sulfated or carboxylated polysaccharides (PubChem, 2024). These molecules are vital for physiological functions such as the regulation of the coagulation cascade, maintenance of membrane potential, and mediation of cell-cell interactions (NIH, 2023). In pharmacology, these anionic entities are targeted by cationic or ion-exchange drugs that bind through electrostatic attraction. For example, protamine sulfate is a highly cationic peptide employed to neutralize heparin's anticoagulant activity (StatPearls, 2023). Additionally, bile acid sequestrants and phosphate binders, such as sevelamer, remove specific anions from the gastrointestinal tract to treat hyperlipidemia and hyperphosphatemia (Mayo Clinic, 2024). Furthermore, certain antibiotics like polymyxins exploit the anionic nature of bacterial surfaces to achieve selective toxicity, although non-specific binding to host polyanions remains a significant therapeutic challenge (Nature Reviews Microbiology, 2019).
Electrostatic neutralization and sequestration of negatively charged molecules or surfaces to inhibit their biological activity or facilitate their removal.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anionic biomolecules and surfaces.